Webinar: Fighting Fraud in a Pandemic: The False Claims Act’s New $2 Trillion Battlefield – Part II

Join us for this Two Part Series May 1 & 8, 2020.

The federal False Claims Act (FCA) was born more than 150 years ago in a time of war. Now, amid another national crisis, the venerable statute will again be deployed in the fight against COVID-19 fraud. Originally aimed at profiteers who sold worthless goods to the Union Army, the FCA has long been a tool against fraudulent claims on federal taxpayer money. With $2 trillion starting to flow into the U.S. economy under the CARES Act, much of it based solely on the self-representation of recipients, the U.S. Department of Justice will rely on the FCA to pursue an inevitable wave of stimulus fraud. This two-part webinar will sketch the new FCA landscape for attorneys on all sides of the issue, from whistleblower lawyers and AUSAs to defense attorneys and in-house counsel. The first session will focus on healthcare fraud in a new and changing environment of CMS rule revisions and regulatory waivers, Stark Act waivers, hard-to-police treatments including telemedicine, and unethical practices such as fraudulent COVID-19 testing and treatments, kickbacks, identity theft, stockpiling and price gouging. The second session will examine grant fraud, the SBA Paycheck Protection Program (PPP), and procurement fraud—and also will focus on the DOJ’s COVID-19 fraud and enforcement structures in light of this pandemic. We’ll conclude with a look at the pandemic’s effect on ongoing FCA cases, offering tips on how to navigate the new landscape.

Register just once to attend both parts of this TWO PART SERIES. Part I takes place at the same time a week earlier, on May 1, 2020.

Registration is now closed

About the Presenters

Deidre Lamppin Colson,  Assistant U.S. Attorney, Southern District Of Alabama
For the past 12 years, Deidre L. Colson has served as an Assistant U.S. Attorney for the Southern District of Alabama, primarily prosecuting Health Care Fraud pursuant to the False Claims Act, Stark Law, Anti-Kickback Statute, and the Controlled Substance Act. Since 2013, she has held the position of Civil Health Care Fraud Coordinator, has held the position of Electronic Discovery Coordinator for 6 years, and was recently appointed as the Religious Liberty Litigation Coordinator in response to the Attorney General’s October 6, 2017, Memorandum. AUSA Colson has also served in the Appellate Division conducting En Banc oral argument before the Eleventh Circuit, and has supervised the Southern District of Alabama’s Financial Litigation Unit, which is responsible for enforcing the collection of criminal and civil debts owed to the United States or to victims of federal crimes pursuant to the Mandatory Victim Restitution Act.

Megan Jeschke, Partner, Holland & Knight
Megan Jeschke is a partner at Holland & Knight and a member of the firm’s White Collar Defense and Investigations, Compliance Services, and Government Contracts teams. She is a litigator with an emphasis on civil and criminal enforcement matters in the government contracts, healthcare, and pharmaceutical industries. She represents companies facing criminal, civil, or administrative actions brought by the U.S. Department of Justice (DOJ) or agency Offices of Inspectors General (OIG), to include qui tam actions brought by relators under the civil False Claims Act (FCA), in the areas of procurement fraud, healthcare fraud, public corruption and procurement integrity, and whistleblower reprisal.

R. Scott Oswald, Chair, FBA Qui Tam Section
Scott Oswald is an accomplished trial lawyer who has brought more than 40 trials to verdict. His cases have recovered more than $300 million in judgments and settlements. A fellow of the prestigious College of Labor and Employment Lawyers, he received his law degree from Howard University and honed his skills at Trial Lawyers College, founded by the legendary Gerry Spence. Mr. Oswald litigates employment and whistleblower actions nationwide. Mr. Oswald is chair of the Federal Bar Association’s Qui Tam Section and immediate past chair of the FBA’s Professional Ethics Committee

Rachel V. Rose, Principal, Rachel V. Rose, Attorney at Law, PLLC
Rachel V. Rose, JD, MBA, advises clients on healthcare, cybersecurity and qui tam matters. She also teaches bioethics at Baylor College of Medicine. She has been consecutively named by Houstonia Magazine as a Top Lawyer (Healthcare), the National Women Trial Lawyer’s Top 25 and the National Trial Lawyers Top 100.

Jennifer A. Short, Partner, KaiserDillon PLLC
Jennifer A. Short is a partner at KaiserDillon PLLC, in Washington, DC, where she focuses on internal and government investigations, compliance matters, and civil litigation. A former Assistant United States Attorney for the District of Columbia, Ms. Short has particular expertise in False Claims Act matters, including multiple-week jury trials involving government contractors and healthcare providers.

Registration

Registration Fees

• FBA Member: $0
• Nonmember: $75

How to Register

Register just once to attend both parts of this TWO PART SERIES. Part I takes place at the same time a week earlier, on May 1, 2020.

Registration is now closed

Cancellation Policy

No refunds will be made for cancellations received after the close of business on April 24, 2020. No-shows will be billed. Substitutions may be made at any time upon notification. Please contact Laura Mulhern at lmulhern@fedbar.org with cancellation and/or substitution requests.

Please note that CLE credit is not offered for this webinar.

If you have any questions regarding this program, please contact Laura Mulhern, Sections and Divisions Manager.